Cargando…
Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730321/ https://www.ncbi.nlm.nih.gov/pubmed/33291692 http://dx.doi.org/10.3390/ijms21239265 |
_version_ | 1783621656789385216 |
---|---|
author | Krzystanek, Marek Krzystanek, Ewa Skałacka, Katarzyna Pałasz, Artur |
author_facet | Krzystanek, Marek Krzystanek, Ewa Skałacka, Katarzyna Pałasz, Artur |
author_sort | Krzystanek, Marek |
collection | PubMed |
description | Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a key element of the PLD-dependent secondary messenger system. Changes in PLD activity are associated with the mechanism of action of olanzapine, an atypical antipsychotic. The aim of the present study was to assess the effect of short-term administration of the first-generation antipsychotic drugs haloperidol, chlorpromazine, and fluphenazine on membrane PLD activity in the rat brain. Animals were sacrificed for a time equal to the half-life of the antipsychotic drug in the brain, then the membranes in which PLD activity was determined were isolated from the tissue. The results indicate that only haloperidol in a higher dose increases the activity of phospholipase D. Such a mechanism of action of haloperidol has not been described previously. Induction of PLD activity by haloperidol may be related to its mechanism of cytotoxicity. The finding could justify the use of PLD inhibitors as protective drugs against the cytotoxicity of first-generation antipsychotic drugs like haloperidol. |
format | Online Article Text |
id | pubmed-7730321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77303212020-12-12 Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity Krzystanek, Marek Krzystanek, Ewa Skałacka, Katarzyna Pałasz, Artur Int J Mol Sci Communication Membrane phospholipase D (PLD) is associated with numerous neuronal functions, such as axonal growth, synaptogenesis, formation of secretory vesicles, neurodegeneration, and apoptosis. PLD acts mainly on phosphatidylcholine, from which phosphatidic acid (PA) and choline are formed. In turn, PA is a key element of the PLD-dependent secondary messenger system. Changes in PLD activity are associated with the mechanism of action of olanzapine, an atypical antipsychotic. The aim of the present study was to assess the effect of short-term administration of the first-generation antipsychotic drugs haloperidol, chlorpromazine, and fluphenazine on membrane PLD activity in the rat brain. Animals were sacrificed for a time equal to the half-life of the antipsychotic drug in the brain, then the membranes in which PLD activity was determined were isolated from the tissue. The results indicate that only haloperidol in a higher dose increases the activity of phospholipase D. Such a mechanism of action of haloperidol has not been described previously. Induction of PLD activity by haloperidol may be related to its mechanism of cytotoxicity. The finding could justify the use of PLD inhibitors as protective drugs against the cytotoxicity of first-generation antipsychotic drugs like haloperidol. MDPI 2020-12-04 /pmc/articles/PMC7730321/ /pubmed/33291692 http://dx.doi.org/10.3390/ijms21239265 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Krzystanek, Marek Krzystanek, Ewa Skałacka, Katarzyna Pałasz, Artur Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity |
title | Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity |
title_full | Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity |
title_fullStr | Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity |
title_full_unstemmed | Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity |
title_short | Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity |
title_sort | enhancement in phospholipase d activity as a new proposed molecular mechanism of haloperidol-induced neurotoxicity |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730321/ https://www.ncbi.nlm.nih.gov/pubmed/33291692 http://dx.doi.org/10.3390/ijms21239265 |
work_keys_str_mv | AT krzystanekmarek enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity AT krzystanekewa enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity AT skałackakatarzyna enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity AT pałaszartur enhancementinphospholipasedactivityasanewproposedmolecularmechanismofhaloperidolinducedneurotoxicity |